---
title: "PRESS RELEASE: Eqs-Adhoc: Merck Kgaa Confirms Discussions With Springworks Therapeutics, Inc. On Potential Acquisition"
date: "2025-02-11 03:08:00"
summary: "EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition 10-Feb-2025 / 20:06 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group...."
categories:
  - "Dow Jones Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Dow Jones Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

```
EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover   
Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition   
10-Feb-2025 / 20:06 CET/CEST   
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News   
- a service of EQS Group.   
The issuer is solely responsible for the content of this announcement.   
-----------------------------------------------------------------------------------------------------------------------   
Darmstadt, February 10, 2025 - Merck KGaA ("Merck") reacts to press reports and confirms advanced discussions with   
Springworks Therapeutics, Inc. Merck also confirms that no legally binding agreement has been entered into. There is no   
certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met.   
End of inside information   
   
Contact Merck KGaA   
Dr. Gangolf Schrimpf   
Merck KGaA   
Frankfurter StraXXX223e 250   
64293 Darmstadt   
Germany   
Phone: +49 6151 729591   
Email: gangolf.schrimpf@merckgroup.com   
Internet: https://www.merckgroup.com/   
ISIN: DE0006599905   
WKN: 659990   
Indices: DAX   
Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Duesseldorf, Hamburg,   
Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX   
   
End of Inside Information   
-----------------------------------------------------------------------------------------------------------------------   
10-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press   
Releases.   
Archive at www.eqs-news.com   
-----------------------------------------------------------------------------------------------------------------------   
Language:     English   
Company:      Merck KGaA   
              Frankfurter Str. 250   
              64293 Darmstadt   
              Germany   
Phone:        +49 (0)6151 72 - 2702   
E-mail:       insiderregister@merckgroup.com   
Internet:     https://www.merckgroup.com/de   
ISIN:         DE0006599905   
WKN:          659990   
Indices:      DAX   
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf,   
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX   
EQS News ID:  2084015   
   
End of Announcement  EQS News Service   
------------- 
```

2084015 10-Feb-2025 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show\_t\_gif&application\_id=2084015&application\_name=news&site\_id=dow\_jones%7e%7e%7e43f1f857-252a-44a4-bbde-f4a32f6a5492

[Dow Jones Newswires](https://www.tradingview.com/news/DJN_DN20250210008675:0/)
